Advertisement
Screener

Altamira Therapeutics Ltd. (CYTOF) Form 6-K: Report of foreign private issuer

Altamira Therapeutics Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-08-29: Form 6-K; Period of report 2025-06-30; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0254753-6k_altamira.htm.
  • 2025-06-11: Form 6-K; Period of report 2025-06-11; Description FORM 6-K; Document ea0245271-6k_altamira.htm.
  • 2025-05-09: Form 6-K; Period of report 2025-05-09; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0241380-6k_altamira.htm.
  • 2025-04-30: Form 6-K; Period of report 2025-04-30; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0240160-6k_altamira.htm.
FiledFormPeriod of reportDescriptionDocument
2025-08-296-K2025-06-30REPORT OF FOREIGN PRIVATE ISSUERea0254753-6k_altamira.htm
2025-06-116-K2025-06-11FORM 6-Kea0245271-6k_altamira.htm
2025-05-096-K2025-05-09REPORT OF FOREIGN PRIVATE ISSUERea0241380-6k_altamira.htm
2025-04-306-K2025-04-30REPORT OF FOREIGN PRIVATE ISSUERea0240160-6k_altamira.htm
2025-03-106-K2025-03-10REPORT OF FOREIGN PRIVATE ISSUERea0233793-6k_altamira.htm